Discover how visionaries in tissue engineering and regenerative medicine navigate the complex path from lab-based research to global impact. This interactive evening features two distinguished leaders sharing their unique perspectives: one scaling an established biotech firm through global uncertainty and one pioneering a transformative startup path.

Our speakers will highlight the operational challenges, regulatory hurdles, and strategic pivots of building MedTech ventures, including navigating the "black swan" events of a pandemic, managing international tariffs, and the grit required to secure fundraising and clinical partnerships. Through engaging storytelling and conversation, attendees will gain deep insights into the leadership experience and the roadmap for taking an idea from the lab to the patient’s bedside.

Guest Speakers:
The Leader: Dr. Stephanie Willerth, CEO of Axolotl Biosciences
Dr. Stephanie Willerth is a biomedical engineer, entrepreneur, and thought leader in 3D bioprinting and neural tissue engineering. As CEO of Axolotl Biosciences and a Full Professor at the University of Victoria, she leads innovations in personalized medicine through bioink development and human tissue models. Her work bridges academia and industry, bringing groundbreaking research into real-world healthcare applications.

The Founder: Eshan Velayati , CEO of AlloWide Health Ehsan Velayati is the CEO and Co-Founder of AlloWide Health Inc., a Canadian
regenerative medicine company developing next-generation solutions for bone repair and
tissue regeneration. With over 20 years of experience in entrepreneurship and business development, he has founded and scaled multiple ventures and built strategic partnerships across healthcare,innovation, and commercialization ecosystems.